Dados B3 › RADL3
RADL3 (Raia Drogasil): has profit grown?
RADL3 (Raia Drogasil): in 2025, net income attributable to controlling shareholders was R$ 1.3 billion, up 8% versus 2024 (a profit of R$ 1.2 billion); five years earlier (2020), a profit of R$ 484.4 million.
| Year | Profit (loss) | Change |
|---|---|---|
| 2025 | R$ 1.3 billion | up 8% |
| 2024 | R$ 1.2 billion | up 14% |
| 2023 | R$ 1.1 billion | up 6% |
| 2022 | R$ 996.1 million | up 32% |
| 2021 | R$ 751.9 million | up 55% |
| 2020 | R$ 484.4 million | down 37% |
| 2019 | R$ 772.2 million | up 54% |
| 2018 | R$ 502.4 million | down 2% |
| 2017 | R$ 511.2 million | up 14% |
| 2016 | R$ 447.7 million | — |
Annual statements (DFP). Profit attributable to controlling shareholders when the company reports it; otherwise total net income. Fact with its source; not investment advice.
Check it yourself
- Open data, no key needed for WEGE3 and with a free key for any company:
https://dadosb3.com/empresas/RADL3/fatos - Every annual figure comes from the DFP filed with the CVM (dados.cvm.gov.br); dividends come from B3.
- The company page shows the account each number came from: RADL3.
Dividends · Debt · Full page · How much it returned · plain text for AI
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:10 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:10 UTC. If this does not match /saude, you are reading a cached copy.